Hymenocardia acida (H. acida) is an African well-known shrub recognized for numerous medicinal properties, including its cancer management potential. The advent of nanotechnology in delivering bioactive medicinal plant extract with poor solubility has improved the drug delivery system, for a better therapeutic value of several drugs from natural origins. This study aimed to evaluate the anticancer properties of H. acida using human lung (H460), breast (MCF-7), and colon (HCT 116) cancer cell lines as well as the production, characterization, and cytotoxicity study of H. acida loaded into PLGA nanoparticles. Benchtop models of Saccharomyces cerevisiae and Raniceps ranninus were used for preliminary toxicity evaluation. Notable cytotoxic activity in benchtop models and human cancer cell lines was observed for H. acida crude extract. The PLGA nanoparticles loading H. acida had a size of about 200 nm and an association efficiency of above 60%, making them suitable to be delivered by different routes. The outcomes from this research showed that H. acida has anticancer activity as claimed from an ethnomedical point of view; however, a loss in activity was noted upon encapsulation, due to the sustained release of the drug.
29 April 2022 in Turkish Journal of Pharmaceutical Sciences
Male infertility has been associated with oxidative stress-induced and/or microbial induced in some men. The use of medicinal plants to overcome oxidative stress-induced infertility cannot be over emphasized. Hence, the aim of this research was to isolate the antilipid peroxidation (an index of usage for treating oxidative stress-induced male infertility) bioactive principle from Momordica charantia using bioactivity-guided isolation. n-Hexane fraction from the crude ethanol extract obtained by Soxhlet extraction of aerial parts (without fruit) of bitter melon, M. charantia, was assessed for in vitro lipid peroxidation, followed by bioactivity-guided isolation of bioactive principles using in vitro lipid peroxidation as an index of aphrodisiac and male fertility enhancer. Fractionation of the active n-hexane fraction using vacuum liquid chromatography (VLC) gave five pooled fractions on the basis of their thin layer chromatography (TLC) characteristics (n-hexane: EtOAc, 2:3, sulphuric acid spray). In vitro activity of the most active VLC fraction C was less than that of the positive control, vitamin E. Further fractionation of VLC-C by open column chromatography on silica gel led to the isolation of a compound which was purified by preparative-TLC. The purified compound, 10 mg/mL (Rf 0.54, TLC silica gel, n-hexane: ethyl acetate; 2:3) was equipotent with vitamin E (25 mg/mL) in reducing peroxidation of polyunsaturated fatty acids in vitro. Structural elucidation by NMR (1H, 13C) and mean mass spectroscopy confirmed the identity of the new bioactive compound as 13, 14-epoxyoleanan-3-ol-acetate. This study scientifically validates the traditional claim of M. charantia as an aphrodisiac or male fertility enhancer and suggests that 13, 14-epoxyoleanan-3-ol-acetate might be responsible for the observed activity.
27 October 2023 in South African Journal of Botany
Cassia siamea (SB) is a common medicinal plant in Southwestern Nigeria, known for its usage in the management of cancer among locals. The study aimed to unveil the claimed anticancer property of SB using cytotoxic bench-top bioassays. Cytotoxicity potential was investigated using Raniceps raninus and Saccharomyces cerevisiae bioassay models, and radical scavenging strength against DPPH stable radical was also unfolded. SB fractionation resulted in three bulked column fractions (SB1 – 3). SB1 was observed to induce severe DNA damage with a percentage mortality of 75.21±5.85%, which is significantly different from 21.85±7.30% p<0.05 observed with 5% DMSO (NC; negative control). The concentration-dependent increase in the mortality of R. raninus, which is an indication of its cytotoxic influence, was noted with SB1 at 10 – 50 µg/mL with 100.00±0.00% mortality observed at 40 and 50 µg/mL. SB1A obtained from SB1 showed the presence of 16 compounds (GC-MS analysis), with caffeic acid found to be the most abundant. Further fractionation of SB1B (obtained from SB1) resulted in pure compound SB1B3 (15.78 mg), which exhibited about 69.82±8.82% mortality of the S.cerevisiae p<0.05 relative to the NC. SB1B3 at 5 – 25 µg/mL also showed 100.00±0.00% mortality of R. raninus at p<0.05 relative to Although the identity of the SB1B3 is yet to be ascertained. The findings of this research confirm that SB possesses cytotoxic potential as claimed by locals.
30 December 2024 in Revista Brasileira de Farmacognosia
Background Hymenocardia acida (HA) is one of the numerous medicinal plants in Nigeria with ethnomedicinal history of usage in the treatment of ulcer. The study aimed at isolating antiulcer principle(s) from the stem bark of HA as well as the mechanism of action determination. Methods Antiulcer screenings of the crude extract, aqueous fraction, and bulked VLC fractions were performed using in vivo and in vitro models. Docking was carried out by using PyRx. Results Crude extract (HA; 1 mg/mL) and the aqueous fraction of H. acida (HAA; 1 mg/mL) showed an acid neutralizing capacity (MEq) of 0.3948 and 0.4035, respectively which is significantly different from 0.431 MEq showed by negative control (distilled water) at p<0.05. BVLC 3 (1 mg/mL) showed a significant value of 0.4049 MEq. However, HA showed a dose-dependent decrease in activity across doses examined, with 100 mg/kg showing an ulcer index of 10.00±2.89 (61.50%) and cimetidine (positive control; 100 mg/kg), also showed the highest ulcer index of 3.67±0.88 (85.9%), which is significantly different from ulcer index of 26.00±6.35 (0.00%) p<0.05 observed in the negative control (5% dimethylsulphoxide). The highest ulcer index of 8.00±1.32 (65.10%) was noted in BVLC 3. Bioactive BVLC 3, resulted in an isolated compound (BF3B2A). The compound was suggested to be lupeol, with a docking score of −7.7. It showed a van der Waal interaction with some key amino acid residues in the vonoprazan binding site. Conclusion The experimental studies justify the ethnomedicinal claim of usage among locals.